These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29248062)

  • 1. Insurers' response to selection risk: Evidence from Medicare enrollment reforms.
    Decarolis F; Guglielmo A
    J Health Econ; 2017 Dec; 56():383-396. PubMed ID: 29248062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual insurance: health insurers try to tap potential market growth.
    November EA; Cohen GR; Ginsburg PB; Quinn BC
    Res Brief; 2009 Nov; (14):1-8. PubMed ID: 19899193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paying more for less? Insurer competition and health plan generosity in the Medicare Advantage program.
    Pelech D
    J Health Econ; 2018 Sep; 61():77-92. PubMed ID: 30099217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open enrollment periods and plan choices.
    Decarolis F; Guglielmo A; Luscombe C
    Health Econ; 2020 Jul; 29(7):733-747. PubMed ID: 32100363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of voluntary disenrollment from Medicare managed care.
    Ng JH; Kasper JD; Forrest CB; Bierman AS
    Med Care; 2007 Jun; 45(6):513-20. PubMed ID: 17515778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality disclosure and the timing of insurers' adjustments: Evidence from medicare advantage.
    McCarthy IM
    J Health Econ; 2018 Sep; 61():13-26. PubMed ID: 30007261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.
    van de Ven WP; van Vliet RC; van Kleef RC
    Eur J Health Econ; 2017 Mar; 18(2):167-180. PubMed ID: 26837411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will choice-based reform work for Medicare? Evidence from the Federal Employees Health Benefits Program.
    Florence CS; Atherly A; Thorpe KE
    Health Serv Res; 2006 Oct; 41(5):1741-61. PubMed ID: 16987300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients.
    Hsu J; Fung V; Huang J; Price M; Brand R; Hui R; Fireman B; Dow WH; Bertko J; Newhouse JP
    Health Aff (Millwood); 2010 Dec; 29(12):2335-43. PubMed ID: 21030394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Medicare managed care market withdrawal on beneficiaries.
    Booske BC; Lynch J; Riley G
    Health Care Financ Rev; 2002; 24(1):95-115. PubMed ID: 12545601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Part D abet advantageous selection in Medicare Advantage?
    Han T; Lavetti K
    J Health Econ; 2017 Dec; 56():368-382. PubMed ID: 29248061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of formal risk adjustment in health plan purchasing.
    Keenan PS; Buntin MJ; McGuire TG; Newhouse JP
    Inquiry; 2001; 38(3):245-59. PubMed ID: 11761352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advertising and Risk Selection in Health Insurance Markets.
    Aizawa N; Kim YS
    Am Econ Rev; 2018 Mar; 108(3):828-67. PubMed ID: 30091563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The individual insurance market before reform: low premiums and low benefits.
    Whitmore H; Gabel JR; Pickreign J; McDevitt R
    Med Care Res Rev; 2011 Oct; 68(5):594-606. PubMed ID: 21427081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012.
    Li P; Doshi JA
    PLoS One; 2016; 11(5):e0154357. PubMed ID: 27149092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unintended effects of the Medicare Part D low income subsidy.
    Decarolis F
    Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse selection and generosity of alcohol treatment benefits.
    Harris KM; Sturm R
    Inquiry; 2002-2003 Winter; 39(4):413-28. PubMed ID: 12638715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Big Five Health Insurers' Membership And Revenue Trends: Implications For Public Policy.
    Schoen C; Collins SR
    Health Aff (Millwood); 2017 Dec; 36(12):2185-2194. PubMed ID: 29200327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Medicare prescription drug proposals and health insurance risk.
    Gencarelli DM
    NHPF Issue Brief; 2003 Sep; (793):1-12. PubMed ID: 12964574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.